The efficacy of polymerized pyridoxylated hemoglobin solution as an O2 carrier.
A polymerized pyridoxylated hemoglobin solution (Poly SFH-P) has been prepared with a normal [Hb] of 14 g/dL, a normal COP of 20 to 25 torr, a P50 of 16 to 20 torr, and a plasma T1/2 of 40 to 46 hours. Animals underwent a total exchange transfusion with Poly SFH-P to assess its ability to support hemodynamics and oxygen transport in the absence of red cells. All animals survived the exchange transfusion. Mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), and oxygen consumption (VO2) remained at baseline values at zero hematocrit after the exchange. The final plasma [Hb] at Hct less than 1% was 9.7 +/- 0.4 g/dL. These results are significantly better than previous data with unmodified tetrameric hemoglobin solution (SFH). Poly SFH-P supports life in the absence of red cells. In contrast to SFH, Poly SFH-P achieves a nearly normal [Hb], a longer T1/2, and maintains baseline hemodynamics and oxygen consumption at zero hematocrit. These results document that Poly SFH-P is an effective oxygen carrier that offers greater potential than previous products as a clinically useful red cell substitute.
Gould
S A
SA
Department of Surgery, Michael Reese Hospital, Chicago, IL 60616.
Sehgal
L R
LR
Rosen
A L
AL
Sehgal
H L
HL
Moss
G S
GS
D000818:Animals; D001802:Blood Substitutes; D005078:Exchange Transfusion, Whole Blood; D006400:Hematocrit; D006439:Hemodynamics / Q000502:physiology; D006454:Hemoglobins; D010101:Oxygen Consumption / Q000502:physiology; D010215:Papio; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives*
D001802:Blood Substitutes; D006454:Hemoglobins; C030939:polyhemoglobin-pyridoxal-5-phosphate; D011732:Pyridoxal Phosphate